权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Antimicrobial Peptides and their Synthetic Mimics - Investigating the Mechanism o

抗菌肽及其合成模拟物 - 研究其作用机制

基本信息

批准号：
8078139
负责人：
David Gidalevitz
金额：
$ 28.65万
依托单位：
ILLINOIS INSTITUTE OF TECHNOLOGY
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-07-01 至 2013-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8078139
关键词：
Advanced Development Air Anti-Bacterial Agents Antibiotics Antimicrobial Resistance Antiviral Agents Bacteria Binding Biological Assay Biological Availability Biomimetics California Cell Wall Cell membrane Cell surface Cells Chemistry Chicago Cholesterol Circular Dichroism Clinical Research Collaborations Communicable Diseases Comparative Study Cytolysis Cytoskeleton Data Development Disease Drug usage Engineering Erythrocytes Event Fluorescence Funding Gram-Negative Bacteria Gram-Positive Bacteria Human Illinois Immune Immune system Incidence Institutes Knowledge Laboratories Left Lipid Bilayers Lipids Liquid substance Los Angeles Lytic Mediating Membrane Membrane Lipids Membrane Proteins Methodology Methods Microscopy Molecular Mono-S Multi-Drug Resistance Mutation N-substituted Glycines Nature Neutrons Oligonucleotides Peptide Antibiotics Peptide Hydrolases Peptides Peptoids Pharmaceutical Preparations Pharmacologic Substance Phosphatidyl glycerol Phosphatidylglycerols Physics Plasma Cells Polymers Property Protozoa Reporting Request for Proposals Research Research Personnel Research Project Grants Resistance Resolution Roentgen Rays Role Science Solid Solutions Staging Structure Structure-Activity Relationship Surface Synchrotrons System Techniques Technology Therapeutic Universities Vesicle Viral Virus Water Work X ray diffraction analysis X-Ray Diffraction analog antimicrobial antimicrobial drug antimicrobial peptide aqueous bacterial resistance base design drug resistant bacteria fungus immunogenicity infrared spectroscopy interest microbicide mimicry monolayer novel novel strategies pathogenic bacteria receptor self assembly solid state viral envelope lipids

项目摘要

DESCRIPTION (provided by applicant): Antimicrobial peptides (AMP) form a first line of defense of the innate immune system and have a broad spectrum of microbicidal activity against a wide range of Gram-negative and Gram-positive bacteria, fungi, protozoa, and even enveloped viruses. Recently they became a matter of increasing interest because of their excellent potential in treating diseases which cannot be cured by conventional antibiotics due to antimicrobial resistance. AMPs either induce membrane damage that is a lethal event for target bacteria or bind to several targets in the cytoplasmic region of the bacteria. All the evidence indicates that the action of the AMPs does not involve stereospecific protein-receptor recognition, since the interactions of AMPs with their targets are generally considered to be nonspecific. Therefore, the character of AMP interaction with bacterial cell wall lipids, viral envelope, or native plasma cell membrane lipids largely determine their lytic potential. As part of our study, novel planar biomimetic membranes, both at air-water and solid-liquid interface will be developed. This will allow use of highly sensitive structural experimental techniques, which cannot be employed with vesicle systems nor with real cells. Furthermore, in addition to AMP we also plan to investigate membrane interactions of their synthetic peptoid mimics (ampetoids), which have an advantage of being protease-resistant, while showing high potency and selectivity as antimicrobial agents. In this highly interdisciplinary proposal we plan to use cutting edge synchrotron X-ray scattering techniques, which together with AFM and epifluorescence studies will yield near atomic resolution of peptide-lipid interaction. These data will be used to advance the understanding of AMP and ampetoids mode of action which can be used to develop rational design strategies for AMPs and antimicrobial peptide mimics to advance development of highly potent drugs that are effective even against multidrug resistant bacteria and viruses. Specific aims of this project are: (1) Examine the modes of interaction of ampetoids and natural AMPs with lipid monolayers representing an outer leaflet of red blood cell membranes and surface layer of bacterial cell wall using synchrotron grazing incidence X-ray diffraction, X-ray reflectivity, epifluorescence microscopy, and AFM used in complementary manner. (2) Design novel fluid bilayer membranes at the air-water interface, use them to examine the interaction of AMPs and ampetoids with both leaflets of bilayer membrane. (3) Design novel cholesterol tethered bilayer lipid membranes (tBLM) with cytoskeleton component. Examine mechanism of AMPs and ampetoids interaction with these tBLMs and elucidate role of cytoskeleton in their interactions. The broader impact of the proposed research is to advance development of novel antibiotic and antiviral drugs that will be immune to bacterial and viral mutations. Antimicrobial peptides and their synthetic mimics have enormous potential with regard to bacterial resistance because they interact not only with specific membrane protein receptors, but also with the lipid matrix of cell membranes, whose lipid composition is highly unlikely to change as a result of bacterial mutation. Better understanding of antimicrobial peptides and peptoids mode of action on molecular level could enhance the design and development of potent alternatives to the conventional antibiotics and antiviral drugs used today.

说明(申请人提供)：抗菌肽(AMP)形成先天免疫系统的第一道防线，对各种革兰氏阴性和革兰氏阳性细菌、真菌、原生动物，甚至包膜病毒具有广泛的杀菌活性。最近，由于它们在治疗由于抗菌素耐药性而无法用常规抗生素治愈的疾病方面的出色潜力，它们成为越来越受关注的问题。AMPS要么导致膜损伤，这对目标细菌来说是致命的事件，要么与细菌细胞质区域的几个靶点结合。所有证据表明，AMP的作用不涉及立体特异性的蛋白受体识别，因为AMP与其靶标的相互作用通常被认为是非特异性的。因此，AMP与细菌细胞壁脂、病毒被膜或天然质膜脂质相互作用的性质在很大程度上决定了它们的裂解能力。作为我们研究的一部分，我们将开发新型的平面仿生膜，包括气-水界面和固-液界面。这将允许使用高度敏感的结构实验技术，而这种技术既不能用于囊泡系统，也不能用于真实细胞。此外，除了AMP之外，我们还计划研究它们的合成肽类模拟物(安培类)的膜相互作用，这些模拟物具有抗蛋白酶的优势，同时显示出作为抗菌剂的高效力和选择性。在这项高度跨学科的提案中，我们计划使用尖端同步加速器X射线散射技术，结合原子力显微镜和荧光研究，将产生近原子分辨率的肽-脂相互作用。这些数据将被用来促进对AMP和安培类药物作用模式的理解，这些数据可以用来制定AMP和抗菌肽模拟物的合理设计策略，以促进高效药物的开发，这些药物甚至可以有效地对抗多重耐药细菌和病毒。本项目的具体目标是：(1)利用同步辐射掠入射X射线衍射、X射线反射率、荧光显微镜和互补使用的AFM，研究安培类和天然AMP与代表红细胞膜外层和细菌细胞壁表层的脂单分子层的相互作用模式。(2)设计了一种新型的气-水界面流体双层膜，并用其研究了AMPs和安替比特与双层膜的两个小叶之间的相互作用。(3)设计具有细胞骨架成分的新型胆固醇栓系双层脂膜(TBLM)。研究AMPs和安培类化合物与这些tBLM的相互作用机制，并阐明细胞骨架在它们相互作用中的作用。拟议研究的更广泛影响是推进新型抗生素和抗病毒药物的开发，这些药物将对细菌和病毒突变具有免疫力。抗菌肽及其合成的模拟物在细菌耐药性方面具有巨大的潜力，因为它们不仅与特定的膜蛋白受体相互作用，而且与细胞膜的脂基质相互作用，而细胞膜的脂组成极不可能因细菌突变而改变。在分子水平上更好地了解抗菌肽和类肽的作用方式，可以促进当今使用的传统抗生素和抗病毒药物的有效替代品的设计和开发。

项目成果

期刊论文数量（14）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

A comparative study on the interactions of SMAP-29 with lipid monolayers.

DOI：
10.1016/j.bbamem.2009.09.017
发表时间：
2010-05
期刊：
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
影响因子：
3.4
作者：
Neville, Frances;Ivankin, Andrey;Konovalov, Oleg;Gidalevitz, David
通讯作者：
Gidalevitz, David

Antibacterial properties and mode of action of a short acyl-lysyl oligomer.

短酰基-赖氨酰低聚物的抗菌特性和作用方式。

DOI：
10.1128/aac.00010-09
发表时间：
2009
期刊：
Antimicrobial agents and chemotherapy
影响因子：
4.9
作者：
Zaknoon,Fadia;Sarig,Hadar;Rotem,Shahar;Livne,Liran;Ivankin,Andrey;Gidalevitz,David;Mor,Amram
通讯作者：
Mor,Amram

Role of the conformational rigidity in the design of biomimetic antimicrobial compounds.

DOI：
10.1002/anie.201003104
发表时间：
2010-11-02
期刊：
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
影响因子：
16.6
作者：
Ivankin, Andrey;Livne, Liran;Mor, Amram;Caputo, Gregory A.;DeGrado, William F.;Meron, Mati;Lin, Binhua;Gidalevitz, David
通讯作者：
Gidalevitz, David

Mechanism of membrane perturbation by the HIV-1 gp41 membrane-proximal external region and its modulation by cholesterol.